Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

To treat or not to treat? That is the question

Lorraine Burgess

Age is a risk factor for both dementia and most cancers and we can hypothesis that we will see more and more people affected by both conditions over future decades. Individuals affected by both cancer and dementia pose unique challenges to healthcare professionals owing to complex factors as impaired mental capacity, consent issues, poor communication and issues of compliance when having to make decisions around oncology treatments. Adjusting to a cancer diagnosis when living with dementia can unfold a variety of emotional and practical responses to receiving news of the diagnosis of cancer and treatment options available and indeed of whether or not to offer or accept treatments. This can be a confusing, frustrating and distressing decision for those working in oncology services as well as for family carers and people living with dementia which may on occasion indicate treatment is not always perceived as in that persons best interest. Therefore the decision of whether to treat or not to treat comes with huge implications both ethically and in relation to quality of life outcomes. This presentation demonstrates the complexities and challenges involved in working as a dementia nurse consultant in a large UK oncology specialist treatment centre which have previously been unexplored.